Very interesting pharmaceutical with very high potential returns
It was already proven that 18-MC doesn’t increase GDNF expression in dopaminergic-like cell cultures of the brain. Way back in 2010 you can go look it up in the October issue of Addiction Biology.
In treatment for alcohol addiction, maybe. More recent studies of its use for treating other substance dependencies show it to be effective
I may have found what you’re referencing: https://pubmed.ncbi.nlm.nih.gov/27984095/